◆英語タイトル:Oncgnostics GmbH - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME404702PD
◆発行会社(調査会社):
GlobalData
◆発行日:2021年1月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company offers pipeline products such as GynTect technology a system based on the detection of epigenetic biomarkers mainly in the methylation of specific DNA regions. Its GynTect also allows a fast and reliable detection of cervical precancerous lesions and cancer. Oncgnostics’ pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors, among others. The company also provides IVD test development field after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oncgnostics GmbH
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
List of Tables
List of Figures
Oncgnostics GmbH Company Overview
Oncgnostics GmbH Company Snapshot
Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
Oncgnostics GmbH – Pipeline Analysis Overview
Oncgnostics GmbH – Key Facts
Oncgnostics GmbH – Major Products and Services
Oncgnostics GmbH Pipeline Products by Development Stage
Oncgnostics GmbH Pipeline Products Overview
GynTecT – CT Assay
GynTecT – CT Assay Product Overview
GynTecT – CT/NG Assay
GynTecT – CT/NG Assay Product Overview
GynTecT – NG Assay
GynTecT – NG Assay Product Overview
GynTecT – TV Assay
GynTecT – TV Assay Product Overview
Oncgnostics Diagnostic Test – Head & Neck Cancer
Oncgnostics Diagnostic Test – Head & Neck Cancer Product Overview
Oncgnostics Diagnostic Test – Ovarian Cancer
Oncgnostics Diagnostic Test – Ovarian Cancer Product Overview
Oncgnostics GmbH – Key Competitors
Oncgnostics GmbH – Key Employees
Oncgnostics GmbH – Locations And Subsidiaries
Head Office
Recent Developments
Oncgnostics GmbH, Recent Developments
Feb 20, 2019: Early detection test GynTect now available on Roche Diagnostics’ QPCR system
May 18, 2018: Oncgnostics and Blink presented BMBF research project “ASSURER”
Sep 27, 2017: Better diagnosis of cervix cancer: New InfectoGnostics project “ASSURER” funded by the BMBF
Sep 20, 2016: Early Detection of Ervical cancer: “ GynTect 2.0“- Wider Range of Application by Using a Greater Variety of Patient Samples
Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India
Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive
Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test “GynTect”
Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
Oncgnostics GmbH Pipeline Products by Equipment Type
Oncgnostics GmbH Pipeline Products by Indication
Oncgnostics GmbH, Key Facts
Oncgnostics GmbH, Major Products and Services
Oncgnostics GmbH Number of Pipeline Products by Development Stage
Oncgnostics GmbH Pipeline Products Summary by Development Stage
GynTecT - CT Assay - Product Status
GynTecT - CT Assay - Product Description
GynTecT - CT/NG Assay - Product Status
GynTecT - CT/NG Assay - Product Description
GynTecT - NG Assay - Product Status
GynTecT - NG Assay - Product Description
GynTecT - TV Assay - Product Status
GynTecT - TV Assay - Product Description
Oncgnostics Diagnostic Test - Head & Neck Cancer - Product Status
Oncgnostics Diagnostic Test - Head & Neck Cancer - Product Description
Oncgnostics Diagnostic Test - Ovarian Cancer - Product Status
Oncgnostics Diagnostic Test - Ovarian Cancer - Product Description
Oncgnostics GmbH, Key Employees
Glossary